TheraRadar
← Back
Data updated: Mar 29, 2026

ANI PHARMS

CardiovascularNeurologyOncology
Generics

ANI PHARMS is a generic drug manufacturer focused on Cardiovascular, Neurology, Oncology.

1952
Since
158
Drugs
-
Trials
1062
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 46%
21 drugs
Neurology 17%
8 drugs
Oncology 15%
7 drugs
Infectious Disease 11%
5 drugs
Gastroenterology 11%
5 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...